Nature Biotechnology featured iGEM and synthetic biology in their most recent issue. There were many articles published in that issue, including opinion pieces on the cost of DNA synthesis, patenting issues, ethics and public policy, and much, much more. This current issue is definitely worth a look to get a feel for the state of synthetic biology now, and I’d strongly recommend those of us who are interested in synthetic biology to take a look at it!
Some points of interest include:
- DNA synthesis costs affecting synthetic biology (linked above)
- Patent issues and the interaction between industry and academia (linked above)
- Whole genome synthesis (a personal favorite!)
- An interview with J. Craig Venter (he’s a big name in synthetic biology)
Enjoy!
Leave a Comment